DRKS00000480RecruitingNot Applicable
Regulation of the Receptor of Advanced Glycation Endproducts in Sepsis after Polytraumatization - RiSaP
Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie0 sites100 target enrollmentStarted: July 21, 2010Last updated:
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Enrollment
- 100
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 Years to one (—)
- Sex
- All
Inclusion Criteria
- •Polytraumatization with ISS>16
Exclusion Criteria
- •terminal kidney insufficiency, Diabetes mellitus, rheumathoid arthritis, Morbus Alzheimer, inflammatory bowel disease, artherisclerosis with previous myocardial ischemia, myocardial bypass surgery, stent implantation surgery
Investigators
Similar Trials
Not yet recruiting
Unknown
Role of inflammatory mediators RAGE, sRAGE for developing atherosclerosis in patients with Diabetes MellitusCTRI/2024/08/072105GB Pant Hospital
Completed
Not Applicable
Clinical evaluation of receptor for advanced glycation endproducts (RAGE) as a biomarker for lung injuryPatients undergoing cardiac surgeryJPRN-UMIN000010674Department of Anesthesiology, Tokyo Medical and Dental University, Graduate School of Medicine90
Completed
Not Applicable
Influence of Acute Respiratory Distress Syndrome (ARDS) and Severe Sepsis on sRAGE Levels in ICU PatientsSevere SepsisMechanical VentilationSeptic ShockAcute Respiratory Distress SyndromeAcute Lung InjuryNCT00811629University Hospital, Clermont-Ferrand60
Recruiting
Unknown
Elucidation of the role of Receptor activator of nuclear factor kappa-B (RANK)/RANK ligand (RANKL) signals in the onset and progression of primary biliary cholangitisprimary biliary cholangitisJPRN-UMIN000053038Tokai University School of Medicine40
Active, not recruiting
Phase 1
A research study to evaluate the safety and efficacy of AT-001 in patients who may be at risk for a heart condition known as diabetic cardiomyopathy (DbCM) as a complication of a type 2 diabetes mellitus (T2DM)Diabetic Cardiomyopathy (DbCM) / Stage B Heart Failure (SBHF)MedDRA version: 20.0Level: PTClassification code 10012647Term: Diabetic cardiomyopathySystem Organ Class: 10007541 - Cardiac disordersEUCTR2019-002558-21-DEApplied Therapeutics Inc.675